In this Section |
258052 Beginning life right: A public health perspective on ethical challenges facing pregnant woman, newborns, and children with special needsMonday, October 29, 2012
The goal of public health is to gain knowledge that will help protect and promote the health of communities and populations. Unlike in medical ethics where individual autonomy is paramount, in public health ethics, the benefits to community may override an individual's autonomy. The Children's Health Act of 2000, passed by Congress and signed into law by former President Clinton, required the establishment of the National Center on Birth Defects and Developmental Disabilities (NCBDDD) at the Centers for Disease Control and Prevention (CDC). In April 2001, the NCBDDD was officially established to promote the health of babies, children and adults and to enhance individuals' potential for full, productive living. This presentation will focus on public health ethical challenges and applications at the NCBDDD and how both research and non-research public health studies can create ethical challenges. In particular, ethical issues will be addressed relating to pregnant women, newborns, and children with special needs during crises, such as floods, natural disasters and in preparations for infectious disease outbreaks, such as the 2009 H1N1 pandemic. Lastly, ethical considerations in genetic testing and newborn screening will be discussed.
Learning Areas:
Ethics, professional and legal requirementsProgram planning Learning Objectives: Keywords: Ethics, Children With Special Needs
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: Cynthia Cassell, PhD, is an epidemiologist in the Birth Defects Branch, CDC and is a member of CDC’s Public Health Ethics Committee. She has degrees in medical ethics and bioethics and did a Fulbright fellowship in bioethics. She has served on a hospital ethics committee and held positions on Institutional Review Boards (a state health department and academic university). She has also served on an Independent Review Board, which assessed ethical issues in clinical trials. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 3282.0: Poster Session I
|